BPF PHARMACEUTIQUE 2011 PDF

Le site ne peut pas fonctionner correctement. Lately the discussion about particle contamination in injectables became a hot topic within the pharmaceutical industry. This is driven by the fact that most of these injectables are packed in glass as a primary packaging material, and this material or the connected handling and filling process is prone for creating a certain particle load within the final product. Based on this requirement all pharmaceutical companies have established an inspection process for their respective products. Today more and more products are packed in Blow Fill Seal BFS containers and therefore, regardless of the underlying process these also need be inspected.

Author:Kazisida Shazahn
Country:Panama
Language:English (Spanish)
Genre:Personal Growth
Published (Last):8 October 2008
Pages:299
PDF File Size:16.38 Mb
ePub File Size:16.35 Mb
ISBN:678-2-29678-996-2
Downloads:96377
Price:Free* [*Free Regsitration Required]
Uploader:Zulujinn



Le site ne peut pas fonctionner correctement. Lately the discussion about particle contamination in injectables became a hot topic within the pharmaceutical industry. This is driven by the fact that most of these injectables are packed in glass as a primary packaging material, and this material or the connected handling and filling process is prone for creating a certain particle load within the final product.

Based on this requirement all pharmaceutical companies have established an inspection process for their respective products. Today more and more products are packed in Blow Fill Seal BFS containers and therefore, regardless of the underlying process these also need be inspected.

In this article we want to show a new approach doing automated visual inspection in BFS containers directly linked to a risk consideration of the filling process. This regulation also applies to clinical investigations on medical devices conducted in the Union. This document is the seventh annual report of the Pharmacovigilance Inspectors Working Group. Association A3P Qui sommes nous?

La Vague 47 Fully automated Particle Inspection in Blow Fill Seal Containers — A new approach Lately the discussion about particle contamination in injectables became a hot topic within the pharmaceutical industry. Afin de vous proposer le meilleur service possible, A3P utilise des cookies.

J'accepte - En savoir plus.

BREAKING CONTROLLING POWERS ROBERT LIARDON PDF

Press releases

Please help out by buying a subscription and keeping LWN on the net. It has its roots in BSD in the very early 's, a history that was not enough to prevent the SCO Group from claiming ownership of it. The purpose behind BPF is to let an application specify a filtering function to select only the network packets that it wants to see. Other packet capture programs also make use of it. On Linux, there is another interesting application of BPF: the "socket filter" mechanism allows an application to filter incoming packets on any type of socket with BPF. In this mode, it can function as a sort of per-application firewall, eliminating packets before the application ever sees them. The original BPF distribution came in the form of a user-space library, but the BPF interface quickly found its way into the kernel.

BALLY SPYHUNTER PDF

Navigation

Ref document number : Country of ref document : EP. Kind code of ref document : A1. Country of ref document : CA.

12F615 DATASHEET PDF

A JIT for packet filters

The aim of the paper is to sketch some tentative elements of a political economy of the production, control and interpretation of technical norms in the pharmaceutical industry. It seeks to follow the life of norms, from their negotiation and production to their implementation at the level of the firm. It builds on the historical strands of institutionalism to analyse the social and institutional construction of an industry, which is deeply structured by regulations and standards. The first part sketches an institutionalist view of norms as institutions and as crucial instruments in the art of governing, and on the determinants of their evolution. The second part seeks to scrutinize how pharmaceutical norms have evolved both through the disruptive impact of crisis and the continuous pressure of industry lobbies leading to compromises between conflicting interests. The difficulties met by regulatory agencies in enforcing norms in an era of growing norm complexity and of internationalized value chains appear in the third part. The fourth and final part analyses how norms are translated by industrial actors, how some actors try to circumvent them, how local arrangements take place.

Related Articles